What is the most appropriate medication for constipation in a healthy 15-year-old adolescent?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Best Medication for Constipation in a 15-Year-Old

Polyethylene glycol (PEG) 17 grams daily is the best first-line medication for constipation in a healthy 15-year-old adolescent.

Primary Recommendation

Start with PEG 17 grams daily mixed in 8 ounces of liquid 1, 2. This recommendation is based on:

  • Strong evidence in adolescents: A 2025 systematic review specifically in children and adolescents demonstrated that PEG is probably more effective than placebo (RR 1.74, moderate certainty evidence) and may be more effective than lactulose (RR 1.35, low certainty evidence) 2
  • Durable response: PEG has shown sustained efficacy over 6 months 1
  • Cost-effective: Monthly cost of $10-45, making it highly accessible 1
  • Safety profile: Well-tolerated with manageable side effects (bloating, abdominal discomfort, cramping) 1

Treatment Algorithm

Step 1: First-Line Therapy

  • PEG 17 grams daily as initial treatment
  • Titrate dose based on symptom response and side effects
  • No clear maximum dose, allowing flexibility 1
  • Ensure adequate hydration (8-10 ounces of fluid with each dose)

Step 2: If PEG Alone is Insufficient

Consider adding fiber supplementation (14 g/1,000 kcal intake per day) for mild-to-moderate symptoms, particularly if dietary fiber intake is deficient 1. However, the 2025 pediatric meta-analysis establishes PEG as the clear standard of first-line care 2.

Step 3: Rescue Therapy for Acute Episodes

  • Bisacodyl 5 mg daily (maximum 10 mg) for short-term use or rescue therapy 1
  • Important caveat: Stimulant laxatives like bisacodyl and senna are recommended only for short-term use; long-term safety and efficacy are unknown 1

Step 4: Refractory Cases

If PEG fails after adequate trial, consider:

  • Linaclotide (FDA-approved in 2023 for children 6-17 years old): 72-145 μg daily 3
    • Increases defecation frequency (mean difference 1.10 bowel movements per week, moderate certainty evidence) 2
    • May have benefit for abdominal pain 1
    • Monthly cost approximately $523 1

Key Clinical Considerations

Why PEG over other options:

  • The 2025 Lancet Child & Adolescent Health meta-analysis explicitly states: "Polyethylene glycol is probably more effective than placebo and key comparator therapies and should be considered the standard of first-line care" 2
  • This represents the most recent, highest-quality pediatric-specific evidence available

Common pitfalls to avoid:

  • Don't use stimulant laxatives (bisacodyl, senna) as first-line maintenance therapy - they lack long-term safety data and are only appropriate for short-term/rescue use 1
  • Don't rely on fiber alone - while fiber can be helpful for mild symptoms, PEG has superior evidence in adolescents 2
  • Don't use magnesium oxide without checking renal function - use with caution in patients with renal insufficiency 1

Newer agents with limited pediatric evidence:

  • Prucalopride showed no significant benefit over placebo in pediatric studies (RR 1.68, low-moderate certainty evidence) 2
  • Linaclotide may not show treatment success superiority over placebo (RR 1.21, low certainty evidence) but does increase defecation frequency 2
  • These agents should be reserved for PEG-refractory cases given their high cost and limited pediatric data

When to escalate care:

  • Failure to respond to PEG after adequate trial (typically 4-8 weeks)
  • Presence of alarm symptoms suggesting organic disease
  • Severe impact on quality of life despite standard therapy

The evidence strongly converges on PEG as the optimal initial choice, balancing efficacy, safety, cost, and pediatric-specific data quality.

References

3
Research

Recent advances in treating constipation in children.

Expert review of gastroenterology & hepatology, 2024

Related Questions

What is the appropriate evaluation and management for a 15-year-old with infrequent bowel movements (approximately one stool every four days)?
What is the recommended treatment regimen for constipation in a school‑age child, including dietary measures and first‑line pharmacologic therapy?
What medication can be given to a 14‑year‑old with a month‑long history of constipation and abdominal discomfort, which improves with vegetable intake, to relieve his symptoms?
What is the appropriate management of constipation in a woman at approximately 5 months gestation who has no bowel movements?
What is the appropriate management for a 5‑month‑old infant who has not passed a bowel movement for three days?
Could prolonged standing cause a woman's lower right abdominal pain and foot paresthesia that lead her to avoid prolonged sitting?
What are the appropriate next steps in evaluation and management for a patient with a one‑year history of a large (~30 cm) abdominal mass extending to the left rib margin and lower right abdomen, presenting only with vague bloating?
Will a muscle relaxant help with a pinched nerve in the neck, a bulging disc in the back, and bursitis, given worsening leg pain?
How should I approach a patient with gestational diabetes mellitus (GDM)?
What history elements and examinations should be obtained when evaluating a new 62‑year‑old patient?
What short‑term opioid bridge (dose, frequency, and duration) should be prescribed for a patient with chronic cervical and lumbar pain, recent steroid injection, currently out of hydrocodone/acetaminophen 5 mg/325 mg, awaiting a transition‑of‑care appointment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.